Glucose-regulated protein58 modulates cell invasiveness and serves as a prognostic marker for cervical cancer

Cancer Science

Volumn 102, Issue 12, 2011, Pages 2255-2263

  Liao, Chia Jung ^a   Wu, Tzu I ^a,b   Huang, Ya Hui ^b   Chang, Ting Chang ^b   Wang, Chia Siu ^b   Tsai, Ming Ming ^a,c   Lai, Chyong Huey ^b   Liang, Ying ^a   Jung, Shih Ming ^b   Lin, Kwang Huei ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^c CHANG GUNG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; CALVASCULIN; CD24 ANTIGEN; GENE PRODUCT; GLUCOSE REGULATED PROTEIN; GLUCOSE REGULATED PROTEIN 58; INSULIN LIKE GROWTH FACTOR BINDING PROTEIN 7; PROTEIN LAMB3; PROTEIN S 100; PROTEIN S100A10; PROTEIN SLPI; PROTEIN TAX1BP1; SOMATOMEDIN BINDING PROTEIN; TUMOR MARKER; UNCLASSIFIED DRUG; PDIA3 PROTEIN, HUMAN; PROTEIN DISULFIDE ISOMERASE; SMALL INTERFERING RNA;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INVASION; CANCER PATIENT; CARCINOGENESIS; CONTROLLED STUDY; FEMALE; GEL ELECTROPHORESIS; HELA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; LUNG METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS INHIBITION; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEOMICS; RECURRENCE FREE SURVIVAL; SQUAMOUS CELL CARCINOMA; TUMOR XENOGRAFT; TWO DIMENSIONAL ELECTROPHORESIS; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA; ADENOCARCINOMA; ADENOSQUAMOUS CARCINOMA; ANIMAL; CANCER TRANSPLANTATION; GENETICS; KAPLAN MEIER METHOD; LUNG TUMOR; METABOLISM; METASTASIS; MIDDLE AGED; PATHOLOGY; RNA INTERFERENCE; SURVIVAL; TUMOR CELL LINE; UTERINE CERVIX TUMOR; XENOGRAFT;

ADENOCARCINOMA; ADULT; AGED; ANIMALS; CARCINOMA, ADENOSQUAMOUS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; FEMALE; HELA CELLS; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MICE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM TRANSPLANTATION; PROGNOSIS; PROTEIN DISULFIDE-ISOMERASES; RNA INTERFERENCE; RNA, SMALL INTERFERING; SURVIVAL ANALYSIS; TRANSPLANTATION, HETEROLOGOUS; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS;

EID: 81855170289     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2011.02102.x     Document Type: Article

References (45)

1. Hakim AA, Dinh TA. Worldwide impact of the human papillomavirus vaccine. Curr Treat Options Oncol 2009; 10: 44-53.
2. Syrjanen KJ. Spontaneous evolution of intraepithelial lesions according to the grade and type of the implicated human papillomavirus (HPV). Eur J Obstet Gynecol Reprod Biol 1996; 65: 45-53.
3. Khanal RC, Nemere I. The ERp57/GRp58/1, 25D3-MARRS receptor: multiple functional roles in diverse cell systems. Curr Med Chem 2007; 14: 1087-93.
4. Hirano N, Shibasaki F, Sakai R et al. Molecular cloning of the human glucose-regulated protein ERp57/GRP58, a thiol-dependent reductase. Identification of its secretory form and inducible expression by the oncogenic transformation. Eur J Biochem 1995; 234: 336-42.
5. Guo GG, Patel K, Kumar V et al. Association of the chaperone glucose-regulated protein 58 (GRP58/ER-60/ERp57) with Stat3 in cytosol and plasma membrane complexes. J Interferon Cytokine Res 2002; 22: 555-63.
6. Chichiarelli S, Gaucci E, Ferraro A et al. Role of ERp57 in the signaling and transcriptional activity of STAT3 in a melanoma cell line. Arch Biochem Biophys 2010; 494: 178-83.
7. Leys CM, Nomura S, LaFleur BJ et al. Expression and prognostic significance of prothymosin-alpha and ERp57 in human gastric cancer. Surgery 2007; 141: 41-50.
8. Chen CD, Wang CS, Huang YH et al. Overexpression of CLIC1 in human gastric carcinoma and its clinicopathological significance. Proteomics 2007; 7: 155-67.
9. Cheng WL, Wang CS, Huang YH et al. Overexpression of a secretory leukocyte protease inhibitor in human gastric cancer. Int J Cancer 2008; 123: 1787-96.
10. Wang CL, Wang CI, Liao PC et al. Discovery of retinoblastoma-associated binding protein 46 as a novel prognostic marker for distant metastasis in nonsmall cell lung cancer by combined analysis of cancer cell secretome and pleural effusion proteome. J Proteome Res 2009; 8: 4428-40.
11. Camerini A, Donati S, Viacava P et al. Evaluation of HER2 and p53 expression in predicting response to docetaxel-based first-line chemotherapy in advanced breast cancer. J Exp Clin Cancer Res 2011; 30: 38.
12. Lopez-Knowles E, O'Toole SA, McNeil CM et al. PI3K pathway activation in breast cancer is associated with the basal-like phenotype and cancer-specific mortality. Int J Cancer 2010; 126: 1121-31.
13. Miao H, Li DQ, Mukherjee A et al. EphA2 mediates ligand-dependent inhibition and ligand-independent promotion of cell migration and invasion via a reciprocal regulatory loop with Akt. Cancer Cell 2009; 16: 9-20.
14. Shih CH, Chen SL, Yen CC et al. Thyroid hormone receptor-dependent transcriptional regulation of fibrinogen and coagulation proteins. Endocrinology 2004; 145: 2804-14.
15. Gadducci A, Tana R, Cosio S, Genazzani AR. The serum assay of tumour markers in the prognostic evaluation, treatment monitoring and follow-up of patients with cervical cancer: a review of the literature. Crit Rev Oncol Hematol 2008; 66: 10-20.
16. Malinowski DP. Multiple biomarkers in molecular oncology. I. Molecular diagnostics applications in cervical cancer detection. Expert Rev Mol Diagn 2007; 7: 117-31.
17. Tiltman AJ. The pathology of cervical tumours. Best Pract Res Clin Obstet Gynaecol 2005; 19: 485-500.
18. Hsu KF, Huang SC, Shiau AL et al. Increased expression level of squamous cell carcinoma antigen 2 and 1 ratio is associated with poor prognosis in early-stage uterine cervical cancer. Int J Gynecol Cancer 2007; 17: 174-81.
19. Bae SM, Min HJ, Ding GH et al. Protein expression profile using two-dimensional gel analysis in squamous cervical cancer patients. Cancer Res Treat 2006; 38: 99-107.
20. Yeom SY, Jang HL, Lee SJ et al. Interaction of testisin with maspin and its impact on invasion and cell death resistance of cervical cancer cells. FEBS Lett 2010; 584: 1469-75.
21. Kaura B, Bagga R, Patel FD. Evaluation of the Pyruvate Kinase isoenzyme tumor (Tu M2-PK) as a tumor marker for cervical carcinoma. J Obstet Gynaecol Res 2004; 30: 193-6.
22. Tong SY, Lee JM, Song ES et al. Functional polymorphism in manganese superoxide dismutase and antioxidant status: their interactions on the risk of cervical intraepithelial neoplasia and cervical cancer. Gynecol Oncol 2009; 115: 272-6.
23. Kim K, Yu M, Han S et al. Expression of human peroxiredoxin isoforms in response to cervical carcinogenesis. Oncol Rep 2009; 21: 1391-6.
24. Choi YP, Kang S, Hong S, Xie X, Cho NH. Proteomic analysis of progressive factors in uterine cervical cancer. Proteomics 2005; 5: 1481-93.
25. Davy ML, Dodd TJ, Luke CG, Roder DM. Cervical cancer: effect of glandular cell type on prognosis, treatment, and survival. Obstet Gynecol 2003; 101: 38-45.
26. Grigsby PW. The prognostic value of PET and PET/CT in cervical cancer. Cancer Imaging 2008; 8: 146-55.
27. Waggoner SE. Cervical cancer. Lancet 2003; 361: 2217-25.
28. Fuller AF Jr, Elliott N, Kosloff C, Lewis JL Jr. Lymph node metastases from carcinoma of the cervix, stages IB and IIA: implications for prognosis and treatment. Gynecol Oncol 1982; 13: 165-74.
29. Celli CM, Jaiswal AK. Role of GRP58 in mitomycin C-induced DNA cross-linking. Cancer Res 2003; 63: 6016-25.
30. Feldman DE, Chauhan V, Koong AC. The unfolded protein response: a novel component of the hypoxic stress response in tumors. Mol Cancer Res 2005; 3: 597-605.
31. Su R, Li Z, Li H et al. Grp78 promotes the invasion of hepatocellular carcinoma. BMC Cancer 2010; 10: 20.
32. Zheng HC, Takahashi H, Li XH et al. Overexpression of GRP78 and GRP94 are markers for aggressive behavior and poor prognosis in gastric carcinomas. Hum Pathol 2008; 39: 1042-9.
33. Du XL, Yang H, Liu SG et al. Calreticulin promotes cell motility and enhances resistance to anoikis through STAT3-CTTN-Akt pathway in esophageal squamous cell carcinoma. Oncogene 2009; 28: 3714-22.
34. Suzuki T, Lu J, Zahed M, Kita K, Suzuki N. Reduction of GRP78 expression with siRNA activates unfolded protein response leading to apoptosis in HeLa cells. Arch Biochem Biophys 2007; 468: 1-14.
35. Kubota H, Suzuki T, Lu J et al. Increased expression of GRP94 protein is associated with decreased sensitivity to X-rays in cervical cancer cell lines. Int J Radiat Biol 2005; 81: 701-9.
36. Bi M, Naczki C, Koritzinsky M et al. ER stress-regulated translation increases tolerance to extreme hypoxia and promotes tumor growth. EMBO J 2005; 24: 3470-81.
37. Sun S, Han J, Ralph WM Jr et al. Endoplasmic reticulum stress as a correlate of cytotoxicity in human tumor cells exposed to diindolylmethane in vitro. Cell Stress Chaperones 2004; 9: 76-87.
38. Yang XR, Xu Y, Yu B et al. CD24 is a novel predictor for poor prognosis of hepatocellular carcinoma after surgery. Clin Cancer Res 2009; 15: 5518-27.
39. Kita Y, Mimori K, Tanaka F et al. Clinical significance of LAMB3 and COL7A1 mRNA in esophageal squamous cell carcinoma. Eur J Surg Oncol 2009; 35: 52-8.
40. Sherbet GV. Metastasis promoter S100A4 is a potentially valuable molecular target for cancer therapy. Cancer Lett 2009; 280: 15-30.
41. Wang Q, Li M, Wang Y et al. RNA interference targeting CML66, a novel tumor antigen, inhibits proliferation, invasion and metastasis of HeLa cells. Cancer Lett 2008; 269: 127-38.
42. Hou Y, Yang L, Mou M et al. Annexin A2 regulates the levels of plasmin, S100A10 and Fascin in L5178Y cells. Cancer Invest 2008; 26: 809-15.
43. Vizioli MG, Sensi M, Miranda C et al. IGFBP7: an oncosuppressor gene in thyroid carcinogenesis. Oncogene 2010; 29: 3835-44.
44. Tanaka Y, Kanai F, Tada M et al. Gain of GRHL2 is associated with early recurrence of hepatocellular carcinoma. J Hepatol 2008; 49: 746-57.
45. L'Esperance S, Popa I, Bachvarova M et al. Gene expression profiling of paired ovarian tumors obtained prior to and following adjuvant chemotherapy: molecular signatures of chemoresistant tumors. Int J Oncol 2006; 29: 5-24.